195 filings
Page 7 of 10
6-K
crjsq
21 Sep 21
THIS AGREEMENT made as of the 25th day of August, 2021
4:02pm
6-K
8a9uq48ktl l7
31 Aug 21
Material Change Report
2:06pm
6-K
0t24dqbmckjb iknsn5h
25 Aug 21
FSD Pharma Inc. 6-K
9:00am
6-K
bny0dd31o
25 Aug 21
Acquisition Advances Company’s Strategic Plan Toward a Diversified Novel Drug Development Pipeline in Psychedelics and Medical Cannabis
9:00am
6-K
4v1u hfjq
12 Aug 21
Management's Discussion and Analysis of Financial Condition and Results of
9:53pm
6-K
51xocj1fpr6v7ivk7
27 Jul 21
Appoints Anthony Durkacz as Interim Chief Executive Officer and Reinstates Zeeshan Saeed as President
9:24am
6-K
7tkk8zo e55hqq7
3 Jun 21
FSD Pharma Inc. 6-K
9:20am
6-K
posn5o2f
17 May 21
FSD Pharma Inc. 6-K
8:08am
6-K
sq5dbhgatld7gwi
13 May 21
FSD Pharma Inc. 6-K
10:32am
6-K
inr1526 xn3jcrxd3m
10 May 21
FSD Pharma Inc. 6-K
8:30am
6-K
x9twa ivpdb1ttxp
7 May 21
Condensed consolidated interim financial statements
4:38pm
6-K
zr1g4rwp
5 May 21
FSD Pharma Inc. Form 6-K
5:01pm
6-K
w0xq9law
5 May 21
Current report (foreign)
11:30am
6-K
ruvf1uqx5 sxh
5 May 21
FSD Pharma Inc. 6-K
8:54am
6-K
gipofy ragdmdw1v
3 May 21
FSD Pharma Inc. 6-K
7:30am
6-K
y21q2gfstl
23 Apr 21
Current report (foreign)
5:24pm
6-K
lh73jdbmzl mnimcqy44
23 Apr 21
FSD Pharma Inc. Form 6-K
9:02am
6-K
zyyzu3t42n2fxy9mfa
7 Apr 21
Current report (foreign)
1:52pm
F-X
hur8f 8zn7
2 Apr 21
Appointment of agent for service of process by issuers registering securities
12:59pm
F-10
eoy p69l7c4ltk7fq8m
2 Apr 21
Registration of securities (Canada)
12:49pm